Seikagaku Corporation

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Seikagaku Corporation

Seikagaku Corporation (生化学工業株式会社, 4548), Pharmaceutical. 5 cross-shareholdings, a board of 10 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YDGT, filed 2026-06-18. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-3134.93.775.266.3230.00937
2023-03-3133.52.275.640.4926.00976
2024-03-3136.22.281.840.0826.00988
2025-03-3139.41.283.922.2530.001,075
2026-03-3136.61.586.326.9930.001,142

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
KAKEN PHARMACEUTICAL CO., LTD.502,5002.11.3
SANTEN PHARMACEUTICAL CO., LTD.1,130,0002.00.4
Maruzen Showa Unyu Co.,Ltd.121,4001.00.6
Mizuho Leasing Company, Limited665,0000.90.2
TECHNO RYOWA LTD.49,1700.30.2

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown